Tag Archive for Reliv International

Reliv Int. Q3 Revenue down 8.2% To $8.3 Million

Reliv International, Inc. (NASDAQ:RELV), a maker of nutritional supplements that promote optimal health, today reported its financial results for the third quarter of 2018.
Reliv reported net sales of $8.3 million for the third quarter of 2018 compared with net sales of $9.1 million in the third quarter of 2017. Net sales in the United States decreased by $583,000 in the third quarter of 2018, which represented an 8.2 percent decline in net sales when compared to the prior-year quarter.
Net sales in Reliv’s foreign markets decreased by $149,000, or 7.5 percent, in the third quarter of 2018 compared with the prior-year quarter.  Net sales in Asia and Mexico increased by 4.8 percent and 21.9 percent, respectively, in the third quarter of 2018, offset by decreases in all other regions.  Net sales in Reliv’s foreign markets decreased by 3.3 percent during the third quarter of 2018 when the impact of foreign currency fluctuation is removed.
Reliv reported a net loss for the third quarter of 2018 of $542,000 (loss per diluted share of $0.29) compared to a net loss of $319,000 (loss per diluted share of $0.17) in the third quarter of 2017.  The loss from operations for the third quarter of 2018

Read more...

Reliv International Reports 2018 Q2 Net Sales Of $8.5 Millon

Reliv International, Inc. (NASDAQ:RELV), a maker of nutritional supplements that promote optimal health, recently reported its financial results for the second quarter of 2018.
Reliv reported net sales of $8.5 million for the second quarter of 2018 compared with net sales of $10.0 million in the second quarter of 2017. Net sales in the United States decreased to $6.3 million in the second quarter of 2018, which represented a 15.0 percent decline in net sales when compared to the prior-year quarter.
Net sales in Reliv’s foreign markets decreased 17.0 percent in the second quarter of 2018 compared with the prior-year quarter.  Net sales in Europe and Asia decreased by 21.2 percent and 10.5 percent, respectively, in the second quarter of 2018, along with decreases in all other regions except for Mexico.
Reliv reported a net loss for the second quarter of 2018 of $978,000 (loss per diluted share of $0.53) compared to a net loss of $520,000 (loss per diluted share of $0.28) in the second quarter of 2017. The loss from operations for the second quarter of 2018 was $940,000 compared to a loss from operations of $508,000 in the same period in 2017.
Results from operations were primarily impacted by the decline in

Read more...

Reliv International Names Ryan Montgomery New CEO

Reliv International Inc. (NASDAQ:RELV) on Wednesday named Ryan Montgomery as its new CEO. The move is effective immediately.
Based in Chesterfield, USA, Reliv is a maker of nutritional supplements that promotes health.
Ryan’s father, Robert Montgomery, Reliv’s current CEO, will continue to serve as Chairman of Reliv’s board. In his new position, Ryan Montgomery will manage the overall operations of Reliv and set the future strategy for the company.
“Robert Montgomery has been CEO for 30 years, and I look forward to leading Reliv International into the future by building onto the strong foundation he and my mother, Sandy Montgomery, built together,” Ryan Montgomery said in a statement.
“We will work to not only remain competitive and relevant, but we aim to modernize Reliv to become leaders of the wellness and direct sales industries.”
Ryan Montgomery joined Reliv as corporate counsel in 1999, establishing the compliance department and assisting international expansion and development. In 2003, he moved to the sales department and was responsible for developing sales strategy worldwide. He was named president of Reliv in 2012.
He is a 1995 graduate of Vanderbilt University with a bachelor’s degree in Economics and he earned his law degree from St. Louis University in 1999.
Reliv is a developer, manufacturer

Read more...

Reliv International Q4 Sales Down 8.5% To $9.9 Million

Reliv International, Inc. (NASDAQ:RELV), a maker of nutritional supplements that promote optimal health, today reported its financial results for the fourth quarter and full year of 2017.

“While our results from operations improved in 2017 when compared to 2016, we remain focused on growing sales through new product and business development by providing additional tools and support with programs to attract new distributors and customers,”  said Ryan A. Montgomery, President.

Fourth-Quarter Results
Reliv reported net sales of $9.9 million for the fourth quarter of 2017, compared with net sales of $10.6 million for the fourth quarter of 2016. U.S. net sales decreased by 8.5 percent for the quarter compared with the same quarter in 2016.  
Net sales outside of the United States increased by 0.6 percent in the fourth quarter of 2017 compared to the prior-year quarter.
Full-Year Results
Reliv reported net sales of $41.8 million for 2017 compared with net sales of $45.5 million in 2016. U.S. net sales decreased to $32.5 million from $35.6 million, a decline of 8.8 percent. 
Net sales in Reliv’s foreign markets for 2017 decreased 6.1 percent compared with net sales for 2016, with 3.4 percent of the decline due to the impact of foreign currency fluctuation as the result

Read more...

Reliv International Q3 Revenue Down 10% To $10.8 Million

Reliv International, Inc. (NASDAQ:RELV), a maker of nutritional supplements that promote optimal health, today reported its financial results for the third quarter of 2017.
Reliv reported net sales of $9.1 million for the third quarter of 2017 compared with net sales of $10.8 million in the third quarter of 2016.  Net sales in the United States decreased to $7.1 million in the third quarter of 2017 compared to $8.6 million in the prior-year quarter. Net sales in Reliv’s foreign markets decreased 9.8 percent in the third quarter of 2017 compared with the prior-year third quarter.  An increase of 32.8 percent in net sales in Asia in the third quarter of 2017 was offset by a decline of 23.6 percent in net sales in Europe, along with decreases in other regions.
Reliv reported a net loss for the third quarter of 2017 of $319,000 (loss per diluted share of $0.17) compared to net income of $134,000 (income per diluted share of $0.07) in the third quarter of 2016.  The loss from operations for the third quarter of 2017 was $334,000 compared to income from operations of $34,000 in the same period in 2016.  The impact to operations from the decrease in third quarter

Read more...

Reliv Q3 Sales Down 12% To 10.8 Million

 
Reliv International, Inc., a maker of nutritional supplements that promote optimal health, today reported its financial results for the third quarter of 2016.
Reliv reported net sales of $10.8 million for the third quarter of 2016 compared with net sales of $12.2 million in the third quarter of 2015. U.S. net sales decreased to $8.6 million from $9.8 million, a decline of 12.1 percent. Net sales in Reliv’s foreign markets for the third quarter of 2016 decreased 9.5 percent compared with net sales in the prior-year third quarter. Absent the impact of foreign currency fluctuation as the result of a stronger U.S. dollar, net sales in Reliv’s foreign markets were flat during the third quarter of 2016 compared to the prior-year quarter.
Reliv reported net income for the third quarter of 2016 of $134,000

Read more...